Grafting of genetically modified cells: effects of acetylcholine release in vivo.
In this study, microdialysis was used to investigate functional recovery of central cholinergic neurons in the forebrain of rats with cortical devascularizing lesions. Mature male rats were unilaterally lesioned by disruption of the pia arachnoid vessels and genetically modified fibroblasts secreting nerve growth factor (NGF) were placed at the site of the lesion. One month following surgery, microdialysis probes were installed in the remaining cortex and were perfused with artificial cerebrospinal fluid (csf) containing neostigmine (5 nM) and/or KCl (100 mM). The basal (non-stimulated) release of acetylcholine (ACh) in the cortex was similar in all experimental groups, whereas KCl stimulated release of ACh was significantly augmented (P < 0.05) in the ipsilateral remaining cortex in lesioned animals that have been implanted with fibroblasts secreting NGF. These results suggest that NGF secreted by genetically engineered fibroblasts modulates neuroplasticity in the adult mammalian CNS and may favour recovery of cortical function following injury.
Maysinger
D
D
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Piccardo
P
P
Goiny
M
M
Cuello
A C
AC
D000109:Acetylcholine / Q000378:metabolism*; D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism; D003956:Dialysis; D005347:Fibroblasts / Q000378:metabolism / Q000637:transplantation*; D005818:Genetic Engineering; D008297:Male; D009388:Neostigmine / Q000494:pharmacology; D009414:Nerve Growth Factors / Q000378:metabolism*; D010841:Pia Mater / Q000098:blood supply; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D009414:Nerve Growth Factors; D009388:Neostigmine; D011189:Potassium Chloride; D000110:Acetylcholinesterase; D000109:Acetylcholine